glyceollin has been researched along with 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol in 1 studies
Studies (glyceollin) | Trials (glyceollin) | Recent Studies (post-2010) (glyceollin) | Studies (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) | Trials (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) | Recent Studies (post-2010) (4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol) |
---|---|---|---|---|---|
92 | 1 | 54 | 76 | 0 | 32 |
Protein | Taxonomy | glyceollin (IC50) | 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol (IC50) |
---|---|---|---|
Phospholipase D2 | Homo sapiens (human) | 0.044 | |
Steroid hormone receptor ERR2 | Homo sapiens (human) | 0.768 | |
Estrogen receptor | Homo sapiens (human) | 0.4554 | |
Progesterone receptor | Homo sapiens (human) | 0.0008 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 9.3325 | |
Estrogen receptor | Mus musculus (house mouse) | 0.0332 | |
Estrogen-related receptor gamma | Homo sapiens (human) | 0.3485 | |
Estrogen-related receptor gamma | Mus musculus (house mouse) | 0.6 | |
Platelet-activating factor acetylhydrolase | Homo sapiens (human) | 0.0005 | |
Phospholipase D1 | Homo sapiens (human) | 4.8 | |
Estrogen receptor beta | Homo sapiens (human) | 0.0527 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bearss, NR; Bhatnagar, D; Boue, SM; Burow, ME; Cleveland, TE; Erhardt, PW; Khupse, RS; Reese, MD; Sarver, JG; Trendel, JA; Wiese, TE | 1 |
1 other study(ies) available for glyceollin and 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
Article | Year |
---|---|
Biomimetic syntheses and antiproliferative activities of racemic, natural (-), and unnnatural (+) glyceollin I.
Topics: Antineoplastic Agents; Biomimetics; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Female; Humans; Magnetic Resonance Spectroscopy; Male; Models, Chemical; Ovarian Neoplasms; Prostatic Neoplasms; Pterocarpans; Receptors, Estrogen; Stereoisomerism | 2011 |